Log In
Print this Print this

SAV001, SAV001-H

  Manage Alerts
Collapse Summary General Information
Company Sumagen Co. Ltd.
DescriptionGenetically modified inactivated HIV vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today